Publications by authors named "Jason Kennedy"

Background: Quitting cigarette smoking can substantially reduce or eliminate the risk of developing numerous chronic diseases. Use of flavored tobacco or nicotine products is commonly cited by adults who smoke cigarettes to be important in helping them reduce or quit smoking. The purpose of this analysis was to understand the association between the levels of use of flavored oral nicotine products and smoking reduction and quitting and how reduction or quitting may differ between predominant users of fruit/other versus mint flavored oral nicotine products after six months of use.

View Article and Find Full Text PDF
Article Synopsis
  • Despite previous trials, it's still unclear how to effectively resuscitate patients with septic shock, prompting a deeper look into individual differences in treatment responses.
  • The study utilized machine learning to predict individual patient risk differences and evaluate how their characteristics affected treatment effectiveness across two large cohorts.
  • Results indicated significant variability in treatment responses; patients predicted to have the highest risks improved with early goal-directed therapy (EGDT), while those at lower risk potentially faced harm from the same treatment.
View Article and Find Full Text PDF

Purpose: Disease heterogeneity in coronavirus disease 2019 (COVID-19) may render the current one-size-fits-all treatment approach suboptimal. We aimed to identify and immunologically characterize clinical phenotypes among critically ill COVID-19 patients, and to assess heterogeneity of corticosteroid treatment effect.

Methods: We applied consensus k-means clustering on 21 clinical parameters obtained within 24 h after admission to the intensive care unit (ICU) from 13,279 COVID-19 patients admitted to 82 Dutch ICUs from February 2020 to February 2022.

View Article and Find Full Text PDF

Background: Acute limb ischemia (ALI) is a morbid and deadly diagnosis. However, existing epidemiologic studies describing ALI predate the introduction of the Affordable Care Act in 2010 and direct oral anticoagulants in 2011. Thus, we synergized the National Inpatient Sample (NIS) and United States Census to define contemporary trends in the incidence, treatment, and outcomes of ALI in the US.

View Article and Find Full Text PDF
Article Synopsis
  • Frailty increases the risk of negative health outcomes after minor stressors, and the Risk Analysis Index (RAI) quantifies frailty, but it's currently limited to in-person interviews and certain datasets.* -
  • The goal of the study was to adapt the RAI for use with ICD-10-CM administrative data, specifically using the National Inpatient Sample (NIS), which involved validating the new RAI-ICD method across different patient populations.* -
  • The study analyzed data from over 9.5 million hospitalized patients and found that RAI-ICD parameters could effectively predict in-hospital mortality and help categorize frailty, showing strong statistical performance (C statistic of 0.810).*
View Article and Find Full Text PDF

Objective: Endovascular aortic repair (EVAR) is a less invasive method than the more physiologically stressful open surgical repair (OSR) for patients with anatomically appropriate abdominal aortic aneurysms (AAAs). Early postoperative outcomes are associated with both patients; physiologic reserve and the physiologic stresses of the surgical intervention. Among frail patients with reduced physiologic reserve, the stress of an aortic rupture in combination with the stress of an operative repair are less well tolerated, raising the risk of complications and mortality.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes sepsis phenotypes using clinical and protein biomarker data from the ProCESS trial, finding two distinct phenotypes based on 20 variables.
  • Phenotype 1 (12% of patients) showed higher levels of inflammation and organ dysfunction, leading to significantly higher 60-day inpatient mortality compared to Phenotype 2 (88% of patients).
  • The effectiveness of early, goal-directed therapy (EGDT) versus usual care also varied by phenotype, with EGDT performing poorly in Phenotype 1 but similarly to usual care in Phenotype 2.
View Article and Find Full Text PDF

Background: Sepsis is the most common cause of acute kidney injury (AKI) in critically ill patients. Four phenotypes (α, β, γ, δ) for sepsis, which have different outcomes and responses to treatment, were described using routine clinical data in the electronic health record.

Research Question: Do the frequencies of AKI, acute kidney disease (AKD), chronic kidney disease (CKD), and AKI on CKD differ by sepsis phenotype?

Study Design And Methods: This was a secondary analysis of a randomized clinical trial of early resuscitation, including patients with septic shock at 31 sites.

View Article and Find Full Text PDF

Background: Sepsis is a common and deadly syndrome, accounting for more than 11 million deaths annually. To mature a deeper understanding of the host and pathogen mechanisms contributing to poor outcomes in sepsis, and thereby possibly inform new therapeutic targets, sophisticated, and expensive biorepositories are typically required. We propose that remnant biospecimens are an alternative for mechanistic sepsis research, although the viability and scientific value of such remnants are unknown.

View Article and Find Full Text PDF

Background: Acute limb ischemia (ALI) carries a 15% to 20% risk of combined death or amputation at 30 days and 50% to 60% at 1 year. Percutaneous mechanical thrombectomy (PT) is an emerging minimally invasive alternative to open thrombectomy (OT). However, ALI thrombectomy cases are omitted from most quality databases, limiting comparisons of limb and survival outcomes between PT and OT.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers used a large ICU study to identify different subtypes of delirium in patients with respiratory failure or shock through a data-driven machine learning approach.
  • The analysis revealed four distinct delirium subtypes, with notable differences in patient characteristics, mortality rates, and duration of symptoms among them.
  • Although all subtypes exhibited long-term cognitive impairment post-delirium, the severity of this impairment did not vary significantly between the subtypes within a follow-up period.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how different classification methods for sepsis patients align with each other in critically ill individuals.
  • There are four subtype strategies based on clinical data, biomarkers, and transcriptomic data that were analyzed in a group of 522 sepsis patients.
  • Findings show significant variability among the subtype classifications, revealing that these strategies do not effectively pinpoint the same patient populations or clinical outcomes.
View Article and Find Full Text PDF

Background: Sepsis is common, deadly, and heterogenous. Prior analyses of patients with sepsis and septic shock in New York State showed a risk-adjusted association between more rapid antibiotic administration and bundled care completion, but not an intravenous fluid bolus, with reduced in-hospital mortality. However, it is unknown if clinically identifiable sepsis subtypes modify these associations.

View Article and Find Full Text PDF

Cardiogenic shock (CS) is a heterogeneous syndrome reflecting a broad spectrum of shock severity, diverse etiologies, variable cardiac function, different hemodynamic trajectories, and concomitant organ dysfunction. These factors influence the clinical presentation, management, response to therapy, and outcomes of CS patients, necessitating a tailored approach to care. To better understand the variability inherent to CS populations, recent algorithms for staging the severity of CS have been described and validated.

View Article and Find Full Text PDF

Progress in improving cardiogenic shock (CS) outcomes may have been limited by failure to embrace the heterogeneity of pathophysiologic processes driving the underlying syndrome. To better understand the variability inherent to CS populations, recent algorithms for describing underlying CS disease subphenotypes have been described and validated. These strategies hope to identify specific patient subgroups with more favorable responses to standard therapies, as well as those who require novel treatment approaches.

View Article and Find Full Text PDF

Importance: Intravenous fluid administration is recommended to improve outcomes for patients with septic shock. However, there are few data on fluid administration for patients with preexisting heart failure with reduced ejection fraction (HFrEF).

Objective: To evaluate the association between preexisting HFrEF, guideline-recommended intravenous fluid resuscitation, and mortality among patients with community-acquired sepsis and septic shock.

View Article and Find Full Text PDF

In a real-world implementation of a machine-learning (ML)-based sepsis early warning system (EWS), Adams et al. found that timely provider response to an alert was associated with improved mortality, highlighting the potential utility of these systems in patient care.

View Article and Find Full Text PDF

Background: A greater understanding of disease heterogeneity may facilitate precision medicine for coronavirus disease 2019 (COVID-19). Previous work identified four distinct clinical phenotypes associated with outcome and treatment responses in non-COVID-19 sepsis patients, but it is unknown if and how these phenotypes are recapitulated in COVID-19 sepsis patients.

Methods: We applied the four non-COVID-19 sepsis phenotypes to a total of 52,274 critically ill patients, comprising two cohorts of COVID-19 sepsis patients (admitted before and after the introduction of dexamethasone as standard treatment) and three non-COVID-19 sepsis cohorts (non-COVID-19 viral pneumonia sepsis, bacterial pneumonia sepsis, and bacterial sepsis of non-pulmonary origin).

View Article and Find Full Text PDF

Importance: The effectiveness of monoclonal antibodies (mAbs), casirivimab-imdevimab and sotrovimab, is unknown in patients with mild to moderate COVID-19 caused by the SARS-CoV-2 Delta variant.

Objective: To evaluate the effectiveness of mAb against the Delta variant compared with no mAb treatment and to ascertain the comparative effectiveness of casirivimab-imdevimab and sotrovimab.

Design, Setting, And Participants: This study comprised 2 parallel studies: (1) a propensity score-matched cohort study of mAb treatment vs no mAb treatment and (2) a randomized comparative effectiveness trial of casirivimab-imdevimab and sotrovimab.

View Article and Find Full Text PDF

Importance: Rapid source control is recommended to improve patient outcomes in sepsis. Yet there are few data to guide how rapidly source control is required.

Objective: To determine the association between time to source control and patient outcomes in community-acquired sepsis.

View Article and Find Full Text PDF

Background: Lung cancer survival remains poor. The introduction of Intensity-Modulated Radiotherapy (IMRT) allows treatment of more complex tumours as it improves conformity around the tumour and greater normal tissue sparing. However, there is limited evidence assessing the clinical impact of IMRT.

View Article and Find Full Text PDF